UK Devices Bill Offers Medtech An EU MDR Alternative – Or Better?
With the obvious distractions of coronavirus, the UK Medicines and Medical Devices bill has entered its second reading in parliament, accompanied by a drive for it to succeed from the government and opposition parties.
You may also be interested in...
The UK’s post-EU standalone legislation for medical devices has continued its parliamentary journey, reaching the upper house this week. Debate on a clinical registries policy paper has begun.
Post-Brexit planning is now fully back on the agenda in the UK, and work to shape its post-EU medtech regulatory future is also restarting.
Parliamentary committee meetings on the UK’s devices bill have been postponed as measures to tackle COVID-19 have been moved to center stage.